As a result of the Thalidomide disaster the Pearson Commission was set up over 10 years ago with the object of increasing the protection ofthe consumer and now the Consumer Protection Bill is passing through the House. In the meantime, the EEC has had its interests stimulated so that the Directives on Strict Liability of Products will be enforced in 1988. In the past it has been the practice for Great Britain to observe such legislation whilst, in the words of Lord Allen of Abbeydale, the remainder of the EEC tend to observe such regulations in the light of their own modified interpretation. This in the long run tends to put those of us in the UK at a disadvantage.
In a nutshell the change in legislation will mean that the producer is now responsible for ensuring that a product is up to the standard and will perform in the way that he claims. Failure, either in standard of production or performance makes the producer liable, without necessarily having to prove negligence. The definition of 'Producer' will, under certain circumstances, include the suppliers or sellers particularly when they are unable to provide irrefutable evidence of the identity of the manufacturer. Under what circumstances then may the doctor assume the mantle of producer, supplier or seller?
There is a substantial feeling within my profession that anything rather woolly with possibly alarming implications of this kind will either be dealt with by someone else or, hopefully, if we ignore it, it will go away of its own accord. I hasten to add that all doctors with whom I have discussed this matter have full sympathy with the objectives of the legislation.
Three of our Royal Colleges, the Royal College of Surgeons of England, the Royal College of Surgeons of Edinburgh and our Royal College of Physicians have studied the problem in some detail and presented extremely helpful advice. However, the College of Physicians have studied this in a somewhat negative fashion, namely that unless a consultant physician was involved in dispensing drugs for a patient, the new directive was unlikely to affect practice. In point of fact, all doctors and nurses do at times become suppliers of medicines to patients when, for example, they give an injection or even when they provide a patient with some prescribable tablets to tide him or her over the night until the prescription can be honoured by the pharmacist. Even the consultant physician working in a cardiac department will implant cardiac pacemakers and in this age ofrapidly expanding interventional radiology, there are many circumstances when the radiologist may be regarded as the supplier of a product to a patient, but the principal supplier within our profession will become the surgeon who implants various products into the patient.
Medico-legal advice has been sought from the Joint Co-ordinating Committee of the Medical Protection Society and the Medical Defence Union. Their advice was extremely valuable but naturally tempered by caution and their customary warnings that doctors should at all times keep full records. Unfortunately, all doctors have to admit that there are occasions when case records are not as full as we would wish and the reason is usually the limited time available. Even though this may be a fact it is not, and never will be, accepted in a Court of Law.
The British Medical Association in their Annual Report of Council 1987 have considered this subject mainly from the point of view of the European Union of General Practitioners (UEMO) though I happen to know that our representatives within the British Medical Association (BMA) have considered the matter in much greater detail than is expressed in this Annual Report of Council. They are, however, awaiting the progress of the Bill on Consumer Protection passing through the House at present.
The pharmacist and the doctor who undertakes his own dispensing will have to ensure that they record the manufacturer's name, the date of manufacture and the batch number of every item they supply, otherwise under the new laws full liability for the product will devolve onto the pharmacist or dispensing doctor. With the introduction of 'Strict Liability of Products' comes the proposals for 'original packs' of tablets, pills, capsules, etc. By the 'original pack' we mean the cards with each tablet sealed in its own separate compartment. Up to the present if the patient required four of these tablets, the pharmacist or dispensing doctor would cut off the appropriate length of card containing four of these tablets. Under the new regulations of 'original pack', this procedure would immediately transfer the liability for the product from the manufacturer to the pharmacist or dispensing doctor. The proposals in the future are that these packs should be supplied in toto and therefore the multiples in which these packs will be made up will require special consideration. Are they to be in sevens or decimalized in multiples often? Will there be acute packs for a very limited number of tablets and will there be chronic packs to last for say three or four weeks? But if a patient in hospital requires only two days of tablets and the pack consists of more tablets, then any attempt to use the remainder of the tablets for another patient, after the pack has been cut, means a transfer of full liability to the supplier. To destroy the remainder will add considerably to the drug bill of the National Health Service. Is it possible that the NHS will be able to claim Crown Immunity from prosecution if they use residual tablets? This is unlikely considering the decision to waive Crown Immunity when the kitchen hygiene of one hospital was recently under criticism.
Pharmaceutical manufacturers will ofcourse support these proposals regarding original packs and also regarding the Strict Liability as it does give considerable added protection against the possible administration of incorrect drugs or incorrect dosage. In addition, the increased demand for various drugs when the re-use of residual drugs is forbidden is bound to enhance their profits.
Furthermore, the prescriber will be required to issue to the patient in full the manufacturers declaration of all known adverse reactions to the drug. This implies the need for informed consent by the patient and will remove any discretion normally practised by the doctor. Adequate records must be kept that such advice has been given by the doctor and received by the patient.
Many other forms ofmedical and surgical equipment are used by all doctors in addition to pharmaceutical products. Needles, syringes, catheters and surgical dressings, to mention only a few of the commonest.
To what extent will we be expected to record the manufacturers details of these pieces of everyday equipment?
Problems might arise as regards the use of cardiac pacemakers. There are many varieties of these, some specifically designed by technicians to suit the requirements ofpatients and all ofthem are expensive. These pacemakers last for several years and there are various circumstances where a pacemaker can be re-used but the position legally of the doctor re-using this equipment is very questionable under the new regulations. Sometimes the leads break down and new leads have to be implanted. Perhaps these new leads may even be from a different manufacturer. To implant new leads without implanting the pacemaker as well, may load the doctor's liability. Here the profession requires some definitive advice.
The new bill will also cover all surgical instruments, appliances and implants. Surgeons will therefore have to be aware of the implications of the proposed legislation which, as it stands, could make the surgeon liable for the quality of the product unless he can quote the name of the manufacturer, the batch number of the item and prove conclusively that the item concerned has been used only in the manner, and for the purpose, recommended by the manufacturer.
To give a practical and hypothetical example: suppose a balloon on a Foley catheter fails to deflate, creating difficulty removing the catheter, then the customary recommended procedures are practised so that the balloon ultimately dissolves or bursts and the catheter can then be withdrawn. Any retained piece of that burst balloon can be attributed to a fault in the catheter. However, if the doctor who inserted or removed that catheter failed to record the name of the manufacturer and the batch number of the catheter, then liability devolves onto the doctor or surgeon in charge, who shares the liability with the National Health Service. Which doctor will be responsible? Is it the doctor who originally inserted the catheter or is it the doctor who experienced the difficulty deflating the balloon and adopted certain routine procedures for dissolving or bursting the balloon? Are we to expect every doctor to record the manufacturer's name, the date of manufacture and the batch number of every catheter he puts into every patient?
Journal of the Royal Society of Medicine Volume 81 April 1988 201 Furthermore, if the surgeon decided to enlarge one of the drainage holes or add extra drainage holes along the shaft of the catheter, then he would not have used the catheter in accordance with the manufacturer's recommendation and, again, the surgeon would be accepting full liability for any defect in that product irrespective of whether the modification he has made has any bearing on the defect that may subsequently be found.
Surgery is not infrequently a science of improvization. Many are the occasions when, faced with an unforeseen problem in the middle of an operation, the surgeon will decide how best to manage the situation with the equipment available. It is impossible for any theatre superintendent to carry every piece of equipment that might be used under every possible circumstance. Several times I have drained a ureter with a child's oesophageal catheter because this happens to be the right consistency, the right length and the right calibre. Would I have in the future to ensure that this piece of equipment was labelled 'ureteric catheter' and not 'child's oesophageal catheter', even though it may be the same item?
As regards larger and more sophisticated pieces of equipment that are implanted in patients, such as dacron grafts, in many hospitals the name of the manufacturer, the batch number and the date of manufacture have been recorded as a matter of principle. Having removed the graft from its pack the surgeon tailors it to the size required. In this tailoring process he may cut off quite a long length of the dacron graft. The cost of these grafts and the impecunious state of our Health Service means we cannot possibly waste these offcuts which at present are repacked and re-sterilized. Under the new laws will this be permissible?
Another implant that is commonly used is the artificial hip joint. Again, our orthopaedic colleagues record the manufacturer's name, the batch number and date of manufacture, but these details are not by any means a routine procedure, nor is there any standard practice on the part of the manufacturers providing this information. It is therefore suggested that a peel-off adhesive label should be attached to all this type of equipment, it should be of standard size and placed in the same position on the packaging. This peel-off label, rather like the small adhesive address labels would give the manufacturer's name, the date of manufacture and the batch number. When the piece of equipment is used it would be someone's responsibility to peel this off and insert it in the patient's records. A conventional site should be allocated for the insertion of this in the patient's records. If the surgeon at the time is scrubbed up, which in fact is the most likely situation, the responsibility for peeling off this adhesive label falls firmly on the nurse. The senior nurse in our region, our theatre sister and the Royal College of Nursing were all of the opinion that the responsibility would be entirely with the NHS but, taking further legal advice, it seems very likely that the nurse would have to share the responsibility with the NHS in the same way as a miscount of swabs. Our nursing colleagues are therefore strongly advised that the laws on Strict Liability of Products will be a matter which they themselves should consider in some detail.
The use of such adhesive labels for recording manufacturing details would seem perfectly reasonable for expensive 'high tech' equipment, such as dacron grafts or artificial hips. On the other hand, where is the line to be drawn? If these regulations are taken to their logical conclusion our orthopaedic colleagues should record the details of every plate they fix. Do we have to record these details for each screw? Taking this example even further, will we be expected to record the details of every suture and stitch? It is here that the profession requires some guidance as to what level should be regarded as necessary to make these recordings and below what level it is reasonable not to make these detailed recordings which would be an absurd imposition on doctors' limited time.
It was here that I approached other specialist associations and my overseas colleagues.The President of the British Orthopaedic Association was extremely helpful and confirmed my anxiety regarding the need to record details of every screw that is inserted. Amongst our overseas contacts the most helpful advice was received from the other side of the Atlantic where litigation on medical problems has reached a staggering level. There they adopt the practice of peeloff labels but in addition nurses are expected to make their own recordings in their own theatre books of the same details of every piece of equipment implanted. However, even in a country so beset with medico-legal disputes, there is no prescribed level at which these recordings stop and this is left entirely to the discretion of the hospital itself. In America each hospital is its own self accounting unit and has its own list of items that have to be recorded in this manner.
As regards the remainder of the EEC the only three countries who gave any helpful reply to enquiries were the Netherlands, Italy and Spain. In the Netherlands Strict Liability of Products is in practice and details are recorded in much the same manner as in America. In Italy and Spain they have studied the situation in detail but have taken no firm action at present. As far as I can gather the other countries have not considered the matter in any great detail and the subject has not been discussed at the EEC Monospecialists Committees to date. The only discussion appears to have been at the UEMO.
On the other hand, our surgical colleagues can be reassured that in the two countries, America and The Netherlands, where this has been implemented, it does not appear to have created too much difficulty and the practice has now become routine for the doctors and nurses concerned. Furthermore, the system does appear to have a research value. Computer recordings of product details can help to trace weaknesses or time deterioration in certain implants, or perhaps in other material used. Sothere may be a brighter side to this problem if the adhesive strips can be designed to be read by a computer in the same way as large stores or libraries record items purchased or loaned. Most surgeons consider this procedure for recording these details perfectly reasonable provided it is not carried so far that every small item used, such as sutures, has to be recorded.
What part does the British Standards Institute (BSI) play in these deliberations? It has often been stated that all products used in the NHS should come up to the standards laid down by BSI, but broadly speaking an instrument that carries the kite sign will be more expensive. This raises questions of economy in a service already stretched to financial limits and this was discussed at length in the Commodity Advisory Group on Surgical Instruments for the Health Service Supply Council with particular reference to surgical instruments in the Central Sterile Supply Departments' (CSSD) dressing packs. These instruments are not used for meticulously detailed procedures; they are transported backwards and forwards between the CSSD and the wards or outpatient departments and they are subject to various forms of loss, petty pilfering or even incineration to a total value of some £3000 to £4000 per year in a major hospital. Unfortunately, all forms of security checking proved to be more expensive still. It was agreed therefore that cheaper sub-standard instruments could be accepted for these dressing packs. The second problem with BSI standards was the 'take it or leave it' attitude of foreign manufacturers, whose quality of equipment already met the International Standards Organization (ISO) standards and they saw no reason for bothering with BSI standards. One way in which the BSI could help would be in standardizing the type of adhesive label to be peeled offthese packs. In any case, in our anxiety about the possible implications of this EEC directive for ourselves, we must not lose sight of the primary reasons for imposing these laws, which are consumer protection by quality control and ensuring a standard below which the item is regarded as unacceptable or even a danger to the consumer and it is here that we must rely entirely on BSI and ISO.
Laws are designed to protect society and to maintain the satisfactory parts of society's structure. We must therefore be sure that these very laws do not, at the same time, stagnate development and even impose on our day-to-day practice of medicine and surgery a stranglehold that culminates in defensive attitudes to the detriment of our patients.
In conclusion then, from the doctor's viewpoint, we would welcome some advice, firstly on the possibility of re-use of exceedingly expensive equipment and, secondly, we would welcome the implementation of a peel-off label or a computer-tape read-out provided by the manufacturers of the type I have already mentioned, though we would wish to know at what level the Department of Health feel that this process of detailed recording could be reasonably omitted.
